Changes in Triglyceride Levels Over Time and Risk of Type 2 Diabetes in Young Men
暂无分享,去创建一个
Iris Shai | A. Rudich | A. Tirosh | I. Shai | D. Tekes-Manova | E. Israeli | T. Shochat | I. Kochba | Assaf Rudich | Rafael Bitzur | Amir Tirosh | Eran Israeli | R. Bitzur | Ilan Kochba | Dorit Tekes-Manova | Tzippora Shochat
[1] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[2] Wei Chen,et al. Correlates of carotid artery stiffness in young adults: The Bogalusa Heart Study. , 2004, Atherosclerosis.
[3] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[4] J. Viikari,et al. The 21‐year follow‐up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east–west difference , 2004, Journal of internal medicine.
[5] Heejung Bang,et al. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. , 2005, Diabetes care.
[6] R. Krauss,et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? , 2005, The American journal of cardiology.
[7] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[8] D. M. Rocha,et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. , 1999, Diabetes.
[9] T. Ryan,et al. Safety and efficacy of percutaneous coronary interventions performed immediately after diagnostic catheterization in northern new england and comparison with similar procedures performed later. , 2000, The American journal of cardiology.
[10] A. Rudich,et al. Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men , 2007, Annals of Internal Medicine.
[11] H. Ginsberg. Nonpharmacologic management of low levels of high-density lipoprotein cholesterol. , 2000, The American journal of cardiology.
[12] M. Laakso,et al. Cardiovascular disease risk factors as predictors of Type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects , 1993, Diabetologia.
[13] P. Whincup,et al. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men , 1995, BMJ.
[14] H. Ginsberg,et al. Regulation of plasma triglycerides in insulin resistance and diabetes. , 2005, Archives of medical research.
[15] Z. Bloomgarden,et al. Type 2 diabetes in the young: the evolving epidemic. , 2004, Diabetes care.
[16] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[17] Richard Kahn,et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.
[18] S. Johansson,et al. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18‐year follow‐up of the BEDA * study , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[19] D. Pereg,et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. , 2005, The New England journal of medicine.
[20] N. Unwin,et al. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .
[21] G. Foster,et al. Physical activity and its effects on lipids , 2003, Current cardiology reports.
[22] E. Barrett-Connor,et al. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. , 1990, American journal of epidemiology.
[23] E. Laws,et al. The effect of clofibrate on glucose tolerance, insulin secretion, triglycerides and fibrinogen in patients with coronary heart disease. , 2009, Acta medica Scandinavica.
[24] M. Kedda,et al. Improved glucose tolerance after effective lipid‐lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle’s cycle in its pathogenesis? , 1997, Clinical endocrinology.
[25] G. Shulman,et al. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.